We are live on ! Find out more
SBH

Segall Bryant & Hamill Portfolio holdings

AUM $6.98B
1-Year Est. Return 34.78%
This Fund
S&P 500
This Quarter Est. Return
-3.97%
1 Year Est. Return
+34.78%
3 Year Est. Return
+85.12%
5 Year Est. Return
+106.02%
10 Year Est. Return
+446.97%
AUM
$8.4B
AUM Growth
-$489M
Cap. Flow
+$10.4M
Cap. Flow %
0.12%
Top 10 Hldgs %
15.04%
Holding
758
New
34
Increased
325
Reduced
263
Closed
36

Top Sells

Rank Stock Value
1
ADBE icon
Adobe
ADBE
+$67.6M
2
SPGI icon
S&P Global
SPGI
+$31.4M
3
VYX icon
NCR Voyix
VYX
+$27.7M
4
CABO icon
Cable One
CABO
+$24.5M
5
CRL icon
Charles River Laboratories
CRL
+$19.8M

Sector Composition

Rank Sector Weight
1 Technology 17.8%
2 Healthcare 17.75%
3 Industrials 16.27%
4 Financials 13.04%
5 Consumer Discretionary 9.39%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AYX
201
DELISTED
Alteryx Inc
AYX
$10.4M 0.12%
186,587
+779
+0.4% +$45.7K
ZWS icon
202
Zurn Elkay Water Solutions
ZWS
$8.38B
$10.3M 0.12%
421,283
+76,059
+22% +$2.17M
LTHM
203
DELISTED
Livent Corporation
LTHM
$10.2M 0.12%
333,054
+6,691
+2% +$188K
WK icon
204
Workiva
WK
$3.36B
$10.2M 0.12%
130,985
-9,260
-7% -$632K
IART icon
205
Integra LifeSciences
IART
$1.29B
$10.1M 0.12%
237,931
+31,566
+15% +$1.62M
EMN icon
206
Eastman Chemical
EMN
$8B
$9.98M 0.12%
140,206
-217,241
-61% -$19.5M
ALKS icon
207
Alkermes
ALKS
$8.22B
$9.95M 0.12%
445,667
+14,606
+3% +$380K
ANGO icon
208
AngioDynamics
ANGO
$611M
$9.94M 0.12%
485,940
+11,094
+2% +$244K
WMT icon
209
Walmart Inc
WMT
$885B
$9.85M 0.12%
227,739
-1,452
-0.6% -$63.6K
OMCL icon
210
Omnicell
OMCL
$1.61B
$9.7M 0.12%
111,493
-1,456
-1% -$153K
MAGN
211
Magnera Corp
MAGN
$472M
$9.58M 0.11%
236,862
-27,206
-10% -$1.89M
NEO icon
212
NeoGenomics
NEO
$1.96B
$9.58M 0.11%
+1,111,874
New +$11M
MMS icon
213
Maximus
MMS
$3.17B
$9.51M 0.11%
164,367
+3,283
+2% +$205K
GLOB icon
214
Globant
GLOB
$1.58B
$9.48M 0.11%
50,698
+556
+1% +$115K
CNMD icon
215
CONMED
CNMD
$1.39B
$9.48M 0.11%
118,214
+17,542
+17% +$1.65M
SHW icon
216
Sherwin-Williams
SHW
$82.7B
$9.45M 0.11%
46,152
+31
+0.1% +$7.34K
WAL icon
217
Western Alliance Bancorporation
WAL
$8.79B
$9.42M 0.11%
143,183
-6,847
-5% -$519K
ABCB icon
218
Ameris Bancorp
ABCB
$5.85B
$9.38M 0.11%
209,859
+27,355
+15% +$1.25M
SPY icon
219
State Street SPDR S&P 500 ETF Trust
SPY
$790B
$9.38M 0.11%
26,251
+1,954
+8% +$776K
KO icon
220
Coca-Cola
KO
$377B
$9.31M 0.11%
166,188
-5,036
-3% -$313K
NOVT icon
221
Novanta
NOVT
$5.08B
$9.3M 0.11%
80,390
+23,717
+42% +$3.23M
INSP icon
222
Inspire Medical Systems
INSP
$1.45B
$9.25M 0.11%
52,130
+1,041
+2% +$209K
FR icon
223
First Industrial Realty Trust
FR
$8.73B
$9.2M 0.11%
205,344
+187,019
+1,021% +$9.46M
POWI icon
224
Power Integrations
POWI
$3.38B
$9.13M 0.11%
141,863
+2,823
+2% +$211K
ORCL icon
225
Oracle
ORCL
$374B
$9.12M 0.11%
149,261
-2,076
-1% -$152K

Similar funds

Segall Bryant & Hamill's Q3 2022 Portfolio in Review

As of Q3 2022, Segall Bryant & Hamill held 758 positions worth $8.4B, down 5.5% from $8.88B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Segall Bryant & Hamill's Q3 2022 filing shows 34 new, 325 increased, 263 reduced and 36 closed positions. Its largest new stake was Ollie's Bargain Outlet: 570,889 shares worth $29.5M. The largest sale was Adobe, an estimated $67.6M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 19% a quarter earlier, followed by Healthcare and Industrials.

  • Segall Bryant & Hamill's largest Q3 2022 buy was Ollie's Bargain Outlet: 570,889 shares worth $29.5M.
  • Segall Bryant & Hamill added most to Novo Nordisk in Q3 2022, an estimated $27.4M increase.
  • Segall Bryant & Hamill's biggest Q3 2022 reduction was Adobe, cutting an estimated $67.6M.
  • Segall Bryant & Hamill fully exited Beacon Roofing Supply, Inc. in Q3 2022, selling an estimated $11.9M.
  • Segall Bryant & Hamill's ten largest holdings make up 15% of its $8.4B portfolio in Q3 2022.
  • Segall Bryant & Hamill opened 34 new positions and closed 36 in Q3 2022.
  • Segall Bryant & Hamill's portfolio value fell 5.5% quarter-over-quarter to $8.4B.

Based on Segall Bryant & Hamill's 13F filing for Q3 2022, filed 14 Nov 2022.